Health-Related Quality of Life in Benign Thyroid Diseases Assessed by ThyPRO: A Systematic Review and Meta-Analysis

PURPOSE: Benign thyroid diseases are common conditions that often require long-term treatment. In some patients, symptoms persist despite normalization of biochemical parameters, significantly affecting quality of life (QoL). This study evaluated treatment-associated changes in QoL using the Thyroid Patient Reported Outcome (ThyPRO) questionnaire and summarized differences in QoL profiles reported across thyroid conditions. METHODS: A systematic review and meta-analysis were performed according to PRISMA guidelines. PubMed, Scopus, and Embase were searched up to April 2024. Data were extracted and synthesized using standardized mean differences. RESULTS: Twenty-five studies were included. Significant pre-post-treatment improvements in overall QoL and selected symptom domains were observed. In Graves' disease, improvements were observed in hyperthyroid symptoms, anxiety, impaired daily life, and overall QoL. In non-toxic goiter, improvements were observed in goiter symptoms, cosmetic complaints, anxiety, tiredness, and overall QoL. In toxic nodular goiter, significant improvements were observed in hyperthyroid and goiter symptoms and overall QoL, whereas several other domains did not change significantly. In hypothyroidism, significant improvements were observed in selected domains, including tiredness, impaired daily life, mood-related symptoms, and overall QoL. Analyses comparing ThyPRO scores between patient groups showed differences in selected domains; these comparisons were interpreted descriptively. CONCLUSIONS: Treatment was associated with improvements in QoL across the analyzed benign thyroid conditions, varying by disease group. Given the heterogeneity of the included studies and the absence of head-to-head comparisons of treatment efficacy across conditions, these findings should be interpreted descriptively. Disease-specific QoL assessment may help clinicians identify persistent symptom domains requiring attention during follow-up.

Authors

Institutions

Publication Details

Journal
Endocrine Connections
Published
2026-10-13
DOI
https://doi.org/10.1530/ec-26-0097
Primary Topic
Thyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Health-Related Quality of Life in Benign Thyroid Diseases Assessed by ThyPRO: A Systematic Review and Meta-Analysis

Angelos Kyriacou, Nadia Sawicka‐Gutaj, Joanna Maciejewska, Barbara Bromińska et al.
Endocrine Connections
Thyroid Disorders and Treatments
article

Health-Related Quality of Life in Benign Thyroid Diseases Assessed by ThyPRO: A Systematic Review and Meta-Analysis

Angelos Kyriacou, Nadia Sawicka‐Gutaj, Joanna Maciejewska, Barbara Bromińska, Aleksandra Derwich-Rudowicz, Kacper Nijakowski, Zachariasz Rytelewski, Paulina Kozłowska, Marek Ruchała, Oliwier Adamczak
article en

Abstract

PURPOSE: Benign thyroid diseases are common conditions that often require long-term treatment. In some patients, symptoms persist despite normalization of biochemical parameters, significantly affecting quality of life (QoL). This study evaluated treatment-associated changes in QoL using the Thyroid Patient Reported Outcome (ThyPRO) questionnaire and summarized differences in QoL profiles reported across thyroid conditions. METHODS: A systematic review and meta-analysis were performed according to PRISMA guidelines. PubMed, Scopus, and Embase were searched up to April 2024. Data were extracted and synthesized using standardized mean differences. RESULTS: Twenty-five studies were included. Significant pre-post-treatment improvements in overall QoL and selected symptom domains were observed. In Graves' disease, improvements were observed in hyperthyroid symptoms, anxiety, impaired daily life, and overall QoL. In non-toxic goiter, improvements were observed in goiter symptoms, cosmetic complaints, anxiety, tiredness, and overall QoL. In toxic nodular goiter, significant improvements were observed in hyperthyroid and goiter symptoms and overall QoL, whereas several other domains did not change significantly. In hypothyroidism, significant improvements were observed in selected domains, including tiredness, impaired daily life, mood-related symptoms, and overall QoL. Analyses comparing ThyPRO scores between patient groups showed differences in selected domains; these comparisons were interpreted descriptively. CONCLUSIONS: Treatment was associated with improvements in QoL across the analyzed benign thyroid conditions, varying by disease group. Given the heterogeneity of the included studies and the absence of head-to-head comparisons of treatment efficacy across conditions, these findings should be interpreted descriptively. Disease-specific QoL assessment may help clinicians identify persistent symptom domains requiring attention during follow-up.

Endocrine Connections
Poznan University of Medical Sciences (PL), European University Cyprus (CY), Salford Royal NHS Foundation Trust (GB)
Openalex Percentile: Top 12%
Thyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.